En cette #JournéeMondialeDeLaSanté comme tous les jours de l’année, nous mettons toute notre énergie au service de nos patients pour leur apporter les meilleurs soins possibles contre le #cancer et faire progresser la recherche médicale pour tous 🤝

Nous étions ravis d'accueillir ce matin Robert Bossy de INRAE MaIAGE pour présenter ses travaux à nos étudiants en maths de CentraleSupélec et clôturer notre concours bibliographique !

[#Podcast] IA et cancer, le diagnostic infaillible ? bit.ly/3eixKoB à (ré)écouter via France Culture #LaMethSci

Classement thématique #Shanghai2021 Université Paris-Saclay conforte sa position d'université de #Recherche intensive de rang international: 🏆1ère en #Mathématique (Monde) 🏆1ère en #Physique (Europe) ...et dans le Top 50 mondial pour 11 disciplines ! 👉 bit.ly/3yOqZEm

A very interesting crop of #cancer papers today in @nature exploring dormancy, cell competition, stem cell niches (h/t Barbara Marte). Thread👇

Important information that may help in the understanding of clonal evolution during interferon therapy in JAK2 and CALR mutated MPNs Great collaboration with Plo isabelle FIM @cerubidine doi.org/10.1182/blood.…

Glad to see the results of our work in collaboration with Plo isabelle and her team at Gustave Roussy published in @BloodJournal. doi.org/10.1182/blood.…

Very pleased to see our paper on inferring the hematopoietic dynamics over IFN therapy, published in this issue of Blood!

Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms loom.ly/8-2JNgc

Happy to share the pre-print of our methodological work, in collaboration with Plo isabelle et al., on mathematical modelling and model selection for inferring the minimal dose in IFNα therapy against #MPN arxiv.org/abs/2112.10688

Hematopoiesis in numbers - check out this #opinion from researchers at @Perielab1 Institut Curie @HustinLucie Jason.cosgrove47 Trends in Immunology #ISSCR2022 hubs.li/Q01dFR_Y0

Very pleased to announce that our paper "Inferring the initiation and development of Myeloproliferative Neoplasms" has been published in PNAS: pnas.org/doi/10.1073/pn… #MPN

4 yrs ago, we discussed with Mathematicians ⁦CentraleSupélec⁩ about integrating Maths in Cancer Research projects⁩. It’s nice to see papers coming on Mathematical models of cancer from our teams. Here a modeling of myeloproliferative disorders 👇 pnas.org/doi/10.1073/pn…

WES & RNAseq landscape of > 1,000 multi-resistant tumors treated Gustave Roussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. CentraleSupélec Prism Center.

Les hémopathies sont des maladies qui induisent un dérèglement de l’hématopoïèse. Les comprendre et ce pour chaque individu, est essentiel pour une prise en charge optimale des patients bit.ly/3gRwgHd

Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues Incyte Hitchcock Lab Plo isabelle and others

How have US Twitter users responded to fluctuating mask recommendations from public health agencies during the pandemic? That is what our research team investigated, using interrupted time series and sentiment/emotion analyses. Check our recent JMIR study: lnkd.in/eTzMhCQh

Large study of RNA-seq in pts w refractory metastatic cancer (n=1031). Pan-cancer analyses. Key msg: high nb of actionable fusions, especially located on PTEN. Certainly a good starting point to evaluate clinical utility of RNA-seq.

A few words (2) of Oral communication by Gurvan Hermange Gurvan Hermange @Perielab1 βiomathematics @BioRugby at #CHO2023 #MathematicalModelling #HSCA

Sopa is now published, read the paper and try it out on your own spatial data!👇 nature.com/articles/s4146…